1

Greg Fenton of Zentek on its new mask manufacturing agreement and US interest in its HVAC filters

In this InvestorIntel interview, host Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg Fenton about its new mask manufacturing and packaging agreement and interest generated from a successful promotional tour in the USA.

In the interview, which can also be viewed in full on the InvestorIntel YouTube channel (click here to access InvestorChannel.com), Greg discusses how Zentek has entered into an agreement with long-established Viva Healthcare Packaging (Canada) Ltd. to manufacture and sell surgical masks enhanced with Zentek’s proprietary ZenGUARD antimicrobial coating. At the height of the pandemic Viva was producing over 20 million masks per month. “They’re big and well established with an existing distribution network,” Greg tells Tracy, “so it was absolutely a perfect partnership for us.”

Greg also talks about his recent visit to Washington, D.C., that included 14 meetings with members of the U.S. Congress, to discuss indoor air quality and Zentek’s ZenGUARD-coated HVAC filters. “We developed a lot of momentum there,” he says. He also talks about ongoing testing of their HVAC filters in real world environments, like classrooms. “The simplicity and elegance of our solution is it’s a passive solution that can be added to any existing system.”

Finally, Greg also talks about Zentek’s finances. “We did a significant capital raise at the beginning of this year and our treasury’s in an excellent position,” he tells Tracy, “but we’re being very judicious in our spending.”

To access the full InvestorIntel interview, click here

Don’t miss other InvestorIntel interviews. Subscribe to the InvestorIntel YouTube channel by clicking here.

About Zentek Ltd.

Zentek is an IP development and commercialization company focused on the research, development and commercialization of novel products using graphene and nanomaterials for use in the healthcare industry and beyond. Zentek’s proprietary ZenGUARD™ coating is patent-pending and shown to have 99% antimicrobial activity, including against COVID-19, for use in PPE and potentially HVAC systems and other industries. Zentek’s ZenGUARD™ production facility is located in Guelph, Ontario.

To know more about Zentek Ltd., click here

Disclaimer: Zentek Ltd. is an advertorial member of InvestorIntel Corp.

This interview, which was produced by InvestorIntel Corp., (IIC), does not contain, nor does it purport to contain, a summary of all the material information concerning the “Company” being interviewed. IIC offers no representations or warranties that any of the information contained in this interview is accurate or complete.

This presentation may contain “forward-looking statements” within the meaning of applicable Canadian securities legislation. Forward-looking statements are based on the opinions and assumptions of the management of the Company as of the date made. They are inherently susceptible to uncertainty and other factors that could cause actual events/results to differ materially from these forward-looking statements. Additional risks and uncertainties, including those that the Company does not know about now or that it currently deems immaterial, may also adversely affect the Company’s business or any investment therein.

Any projections given are principally intended for use as objectives and are not intended, and should not be taken, as assurances that the projected results will be obtained by the Company. The assumptions used may not prove to be accurate and a potential decline in the Company’s financial condition or results of operations may negatively impact the value of its securities. Prospective investors are urged to review the Company’s profile on Sedar.com and to carry out independent investigations in order to determine their interest in investing in the Company.

If you have any questions surrounding the content of this interview, please contact us at +1 416 792 8228 and/or email us direct at info@investorintel.com.